BASF Stock: Buyback and Short Sellers Collide as Agri Strength Offsets Industrial Weakness

BASF's buyback shrinks free float, driving a 19% YTD rally, but hedge fund Marshall Wace boosts short to 0.52% and RSI signals overbought. Key support at €51.

A high-stakes tug-of-war is playing out in BASF shares. The German chemicals giant is aggressively shrinking the number of freely traded shares through a fast-paced buyback, yet hedge fund Marshall Wace has boosted its short position to 0.52%, crossing the disclosure threshold. The opposing forces leave investors trying to gauge whether the stock’s near-19% year-to-date rally has further runway.

The Ludwigshafen-based group has already retired more than 24 million shares under its multi-billion euro repurchase programme, with the current tranche scheduled to conclude by the end of June. Early last month alone, nearly five million shares were pulled from the market. At the same time, Marshall Wace’s elevated net short bet signals deepening scepticism about BASF’s operating environment, even as the company’s own buyback props up the price.

On Thursday, the stock slipped 1.7% intraday to €53.17 before closing at €53.33, just shy of its 52-week high of €54.70. The relative strength index had risen above 70, suggesting the rally was technically overextended. The 50-day moving average at €51 provides the key support level; analysts argue that as long as BASF holds that line, the uptrend of the current year remains intact.

Mixed signals from the sector

The contrasting forces mirror a broader divergence in the chemicals industry. Bayer, a direct competitor in agricultural solutions, posted a near-7% rise in agri-division sales for the first quarter and lifted group operating profit to €4.5 billion, fuelled by new US licenses and robust demand for crop protection and seeds. For BASF, whose Agricultural Solutions unit operates in the same market, the data point is an encouraging tailwind.

But the industrial side tells a different story. Chemical distributor Brenntag saw first-quarter revenue fall roughly 5% to €3.7 billion, with operating profit also shrinking. Weak end-market demand, geopolitical strains and supply-chain disruptions are weighing on volumes, and Brenntag has responded with aggressive cost-cutting that only marginally improved its gross margin.

Europe’s structural headwinds compound the problem. The country’s chemical industry association expects global production growth of 3%, but high energy costs and bureaucracy continue to squeeze margins in Europe. Key customers in automotive and construction remain hesitant to restock, leaving agri and specialty chemicals as the few genuine bright spots.

Cost cuts and insider buying

BASF management is steering through the uneven landscape with tighter cost controls. It now targets €2.3 billion in annual savings by the end of 2026, a marked increase from previous goals. The company also confirmed its full-year outlook, with operating profit set to land between €6.2 billion and €7.0 billion albeit on slightly lower first-quarter sales.

A show of confidence came directly from the finance chief: Dirk Elvermann recently bought company shares worth nearly €46,000, paying an average price of around €51 each. Such insider purchases often provide a floor for sentiment when external bets against the stock are rising.

What’s next

With the buyback set to expire in the summer, a key support pillar will vanish. After that, the share price will have to rely solely on operational delivery. The higher savings target buys the board some breathing room in a tough sector environment, but the divergence between booming agri demand and sluggish industrial orders keeps the risk-reward finely balanced. For now, the bulls hold the upper hand, but the shorts are quietly circling.